Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VOLITIONRX LTDVNRX · Entity 8241 | Director | February 26, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VOLITIONRX LTD
Report date February 26, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 305,816 |
Reported balance
After 2026-02-26 transaction · row 1
1 source rowRow 1 · 2026-02-26 · Grant · Acquired 178,000 · Balance 305,816 F1: On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 30,556 |
Reported balance
Holding disclosure · report date 2026-02-26 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,556 |
Filing footnotes · ownership attribution and instrument terms
F1: On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2026 Filed Feb 27, 2026 21:31 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-001098 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,816 F1 · shares: On February 26, 2026, the reporting person was awarded 178,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on February 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 21:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-26-000359 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,816 F1 · shares: On March 17, 2025, the reporting person was awarded 40,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 20:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 17,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-006096 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,816 F1 · shares: On August 15, 2025, the reporting person was awarded 17,424 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs are earned in six approximately equal monthly installments commencing on August 1, 2025. Once earned, they will remain subject to additional time-based vesting in two equal installments of 8,712 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:06 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 11,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-004374 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,392 F1 · shares: On June 1, 2025, the reporting person was awarded 11,983 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,995 units, 3,994 units, and 3,994 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:02 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 9,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-25-001464 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,409 F1 · shares: On March 1, 2025, the reporting person was awarded 9,893 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,298 units, 3,298 units, and 3,297 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:01 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 8,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-007802 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,516 F1 · shares: On December 1, 2024, the reporting person was awarded 8,648 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,883 units, 2,883 units, and 2,882 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:01 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 9,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-005493 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,868 F1 · shares: On September 1, 2024, the reporting person was awarded 9,171 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 3,057 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:06 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-005034 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,697 F1 · shares: On Sept 28, 2023, the reporting person was awarded 20,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 1,666 units, 1,667 units, and 1,667 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 8,500 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 6,500 RSUs did not vest and were cancelled on August 15, 2024. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 20:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 8,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-003482 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,697 F1 · shares: On June 1, 2024, the reporting person was awarded 8,011 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 2,671 units, 2,670 units, and 2,670 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 21:04 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-24-000411 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,686 F1 · shares: On September 28, 2023, the reporting person was awarded 20,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 8,500 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three installments of 2,834 units, 2,833 units, and 2,833 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. Read SEC document |
| July 05, 2023 Filed Jul 7, 2023 20:01 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 6,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-005114 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,186 F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 6,750 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 2,250 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 2,625 RSUs and 5,625 RSUs subject to the award previously vested and remain subject to time-based vesting. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 21:02 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 5,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-23-000270 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,436 F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 20:01 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-22-007690 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,811 F1 · shares: On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 2,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 5,613 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001477932-22-004665 · form4.xml · derivative · entry 3 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,635 Underlying: Common Stock · 5,613 shares Expires 2031-08-03 F2 · derivative.exercise_date: On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,613 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 2,807 shares and 2,806 shares on each of August 3, 2022 and August 3, 2023, respectively. As reported in April 2022, the rights with respect to the remaining 3,022 shares subject to the award previously vested and remain subject to time-based vesting. F2 · balance_after: On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,613 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two installments of 2,807 shares and 2,806 shares on each of August 3, 2022 and August 3, 2023, respectively. As reported in April 2022, the rights with respect to the remaining 3,022 shares subject to the award previously vested and remain subject to time-based vesting. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 20:05 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 3,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-22-004665 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,186 F1 · shares: On August 3, 2021, the reporting person was awarded 4,686 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 3,046 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 1,523 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in April 2022, the rights with respect to the remaining 1,640 restricted stock units subject to the award previously vested and remain subject to time-based vesting. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 20:03 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantStock Option (Right to Buy) · Derivative | 3,022 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001477932-22-002182 · form4.xml · derivative · entry 3 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,022 Underlying: Common Stock · 3,022 shares Expires 2031-08-03 F2 · derivative.exercise_date: On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 3,022 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 1,511 shares on each of August 3, 2022 and August 3, 2023, respectively. F2 · balance_after: On August 3, 2021, the reporting person was granted an option to purchase 8,635 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 3,022 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 1,511 shares on each of August 3, 2022 and August 3, 2023, respectively. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 20:03 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 1,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001477932-22-002182 · form4.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,140 F1 · shares: On August 3, 2021, the reporting person was awarded 4,686 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 1,640 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two equal installments of 820 units on each of August 3, 2022 and August 3, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| May 14, 2021 Filed May 18, 2021 15:40 UTC | VOLITIONRX LTD VNRX · Entity 8241 | PurchaseCommon Stock | 2,000 | $3.20 | $6,400.00 |
DisclosureSEC source: 0001078782-21-000463 · primary_doc.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 20:43 UTC | VOLITIONRX LTD VNRX · Entity 8241 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001078782-21-000283 · primary_doc.xml · nonDerivative · entry 1 Nguyen Kim · CIK 0001852492 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Ms. Nguyen received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 03/25/22 and 03/25/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.